BioCentury | Aug 3, 2009
Company News

Access Pharmaceuticals, Milestone Biosciences, SpePharm sales and marketing update

...Norway. SpePharm has rights to commercialize MuGard in Europe. Access Pharmaceuticals Inc. (OTCBB:ACCP), Dallas, Texas Milestone BioSciences LLC...
BioCentury | Feb 23, 2009
Company News

Access Pharmaceuticals, Dong-A Pharmaceutical deal

...rinse is approved to treat oral mucositis in the U.S., where it is marketed by Milestone BioSciences LLC...
BioCentury | Aug 25, 2008
Company News

Access Pharmaceuticals, Milestone Biosciences sales and marketing update

...expects to launch MuGard in the U.S. in 1Q09. Access Pharmaceuticals Inc. (OTCBB:ACCP), Dallas, Texas Milestone Biosciences LLC...
Items per page:
1 - 3 of 3
BioCentury | Aug 3, 2009
Company News

Access Pharmaceuticals, Milestone Biosciences, SpePharm sales and marketing update

...Norway. SpePharm has rights to commercialize MuGard in Europe. Access Pharmaceuticals Inc. (OTCBB:ACCP), Dallas, Texas Milestone BioSciences LLC...
BioCentury | Feb 23, 2009
Company News

Access Pharmaceuticals, Dong-A Pharmaceutical deal

...rinse is approved to treat oral mucositis in the U.S., where it is marketed by Milestone BioSciences LLC...
BioCentury | Aug 25, 2008
Company News

Access Pharmaceuticals, Milestone Biosciences sales and marketing update

...expects to launch MuGard in the U.S. in 1Q09. Access Pharmaceuticals Inc. (OTCBB:ACCP), Dallas, Texas Milestone Biosciences LLC...
Items per page:
1 - 3 of 3